(Q73679048)
Statements
The human antimouse immunoglobulin response and the anti-idiotypic network have no influence on clinical outcome in patients with minimal residual colorectal cancer treated with monoclonal antibody CO17-1A (English)
Gruber R
van Haarlem LJ
Warnaar SO
Holz E
Riethmüller G